Home Do I Qualify? Programs Pricing Blog News

Accepting patients

Home Do I Qualify? Programs Pricing Blog News Start Assessment →

Breaking

Clinical & Pharma Intelligence

Losing Weight RX Newsroom

Independent reporting on GLP-1 receptor agonists, clinical trials, and public health policy developments in metabolic medicine.

Original News Coverage Coming Soon

Our editorial team is preparing dedicated clinical trial updates and pharmaceutical news reports. Please check back shortly for updates.

Science-backed, personalized weight loss programs prescribed by licensed U.S. providers. Transparent pricing, free delivery, and ongoing clinical support.

Programs

Semaglutide
Tirzepatide
NAD+
Sermorelin

Company

How it Works
Reviews
Blog
News

Legal

Privacy Policy
Terms of Service
Telehealth Consent
Affiliate Disclosure

Important Affiliate & Medical Disclaimer: Losing Weight RX is an informational website and affiliate marketing platform. We are not a medical provider or pharmacy, and we do not provide medical advice, diagnosis, or treatment. We may earn a commission when you click on links or sign up for a partner's service. The information on this website is for informational purposes only and is not a substitute for professional medical advice. Always consult your physician before starting any medication or weight loss program.

Results May Vary: Individual weight loss results may vary based on starting weight, diet, exercise, and adherence to the clinical program. Testimonials or data provided do not guarantee that you will achieve the exact same results.

FDA & Compounding Disclaimer: Compounded medications (including compounded semaglutide and tirzepatide) are not FDA-approved, meaning the FDA does not evaluate them for safety, efficacy, or quality. They are custom preparations made by licensed compounding pharmacies. Losing Weight RX does not sell, distribute, or claim equivalence to commercially available branded products such as Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. GLP-1 medications may cause serious side effects. Do not use if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Platform Disclaimer: This site is not a part of the Facebook website or Facebook Inc. Additionally, this site is NOT endorsed by Facebook in any way. FACEBOOK is a trademark of FACEBOOK, Inc. This site is not a part of Google™ or the Google network of sites. GOOGLE™ and Google Ads™ are trademarks of Google LLC. Additionally, this site is NOT endorsed by Google LLC in any way.

© 2026 Losing Weight RX. All rights reserved. All treatments prescribed by licensed U.S. providers.